866-997-4948(US-Canada Toll Free)

Endologix, Inc. (ELGX) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Apr 2012

Category :

Surgical Equipment

No. of Pages : 42 Pages


Endologix, Inc. (Endologix) is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its Powerlink Delivery System is an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA; and has certain advantages when compared to marketed stent alternatives. The company has 21 US patents issued, 24 pending US applications, and 22 foreign patents in the area of aorta treatment. Endologix\'s current aorta treatment is related to patents that have expiration dates from 2017 to 2023.

This report is a source for data, analysis and actionable intelligence on the Endologix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Endologix, Inc. - Business Description 5
Key Facts 6
Endologix, Inc. - Major Products and Services 7
Endologix, Inc. Pipeline Products by Equipment Type 8
Endologix, Inc. Pipeline Products by Development Stage 10
Endologix, Inc. Pipeline Products by Therapy Area 12
Endologix, Inc. Pipeline Products by Trial Phase 14
Endologix, Inc. Pipeline Products by Milestone Summary 16
AFX II 18
AFX II Product Status 18
AFX II Product Description 18
Baraitric Stent 19
Baraitric Stent Product Status 19
Baraitric Stent Product Description 19
IntuiTrak Delivery System 20
IntuiTrak Delivery System Product Status 20
IntuiTrak Delivery System Product Description 20
IntuiTrak Delivery System Product Milestone 20
IntuiTrak Delivery System Product Patent Details 21
IntuiTrak Endovascular Delivery System - PEVAR 25
IntuiTrak Endovascular Delivery System - PEVAR Product Status 25
IntuiTrak Endovascular Delivery System - PEVAR Product Description 25
IntuiTrak Endovascular Delivery System - PEVAR Product Milestone 25
Nellix AAA Endovascular System 27
Nellix AAA Endovascular System Product Status 27
Nellix AAA Endovascular System Product Description 27
Nellix AAA Endovascular System Product Milestone 27
Ventana Fenestrated Stent Graft 29
Ventana Fenestrated Stent Graft Product Status 29
Ventana Fenestrated Stent Graft Product Description 29
Ventana Fenestrated Stent Graft Product Milestone 29
Xpand Balloon Expandable Covered Stent 31
Xpand Balloon Expandable Covered Stent Product Status 31
Xpand Balloon Expandable Covered Stent Product Description 31
Endologix, Inc. - Key Competitors 32
Endologix, Inc. - Key Employees 33
Endologix, Inc. - Key Employee Biographies 34
Endologix, Inc. - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Endologix, Inc., Recent Developments 36
Mar 28, 2012: Endologix Announces Retirement Of Franklin D Brown As Chairman 36
Feb 22, 2012: Endologix Reports Revenue Of $83.4m In 2011 36
Oct 27, 2011: Endologix Reports Revenues Of $22.3m In Q3 2011 37
Aug 30, 2011: Endologix Appoints Ruth Lyons As Vice President, Global Marketing 38
Aug 18, 2011: Cook Medical Remains Resolute In Pursuit Of Infringement Action Against Endologix Following Markman Ruling 38
Aug 17, 2011: Endologix Announces Favorable Markman Ruling In Cook Patent Litigation 39
Jul 21, 2011: Endologix Reports Total Revenue Of $19.2m In Q2 2011 39
Jul 18, 2011: Endologix And LeMaitre Vascular Enter Into Early Termination Agreement For European Distribution Rights Of Endologix Products 40
Jun 15, 2011: Endologix To Highlight Complete Product Portfolio At SVS Annual Meeting In New Illinois 41
Apr 21, 2011: Endologix Reports Total Revenue Of $18.5m In Q1 2011 41

Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Table


Endologix, Inc., Key Facts 1
Endologix, Inc. Key Pipeline Products by Equipment Type 1
Endologix, Inc. Key Pipeline Products by Therapy Area 1
Endologix, Inc. Key Pipeline Products by Development Stage 1
Endologix, Inc. Key Pipeline Products by Trial Phase 1
Endologix, Inc., Key Facts 6
Endologix, Inc., Major Products and Services 7
Endologix, Inc. Number of Pipeline Products by Equipment Type 8
Endologix, Inc. Pipeline Products by Equipment Type 9
Endologix, Inc. Number of Pipeline Products by Development Stage 10
Endologix, Inc. Pipeline Products by Development Stage 11
Endologix, Inc. Number of Pipeline Products by Therapy Area 12
Endologix, Inc. Pipeline Products by Therapy Area 13
Endologix, Inc. Number of Pipeline Products by Trial Phase 14
Endologix, Inc. Pipeline Products by Trial Phase 15
Endologix, Inc. Number of Pipeline Products By Milestone Summary 16
Endologix, Inc. Pipeline Products by Milestone Summary 17
AFX II - Product Status 18
AFX II - Product Description 18
Baraitric Stent - Product Status 19
Baraitric Stent - Product Description 19
IntuiTrak Delivery System - Product Status 20
IntuiTrak Delivery System - Product Description 20
IntuiTrak Delivery System - Product Milestone 20
IntuiTrak Delivery System - Patent Details 21
IntuiTrak Endovascular Delivery System - PEVAR - Product Status 25
IntuiTrak Endovascular Delivery System - PEVAR - Product Description 25
IntuiTrak Endovascular Delivery System - PEVAR - Product Milestone 25
Nellix AAA Endovascular System - Product Status 27
Nellix AAA Endovascular System - Product Description 27
Nellix AAA Endovascular System - Product Milestone 27
Ventana Fenestrated Stent Graft - Product Status 29
Ventana Fenestrated Stent Graft - Product Description 29
Ventana Fenestrated Stent Graft - Product Milestone 29
Xpand Balloon Expandable Covered Stent - Product Status 31
Xpand Balloon Expandable Covered Stent - Product Description 31
Endologix, Inc., Key Employees 33
Endologix, Inc., Key Employee Biographies 34
Endologix, Inc., Subsidiaries 35

List of Chart


Endologix, Inc. Key Pipeline Products by Equipment Type 1
Endologix, Inc. Pipeline Products by Equipment Type 8
Endologix, Inc. Pipeline Products by Development Stage 10
Endologix, Inc. Pipeline Products by Therapy Area 12
Endologix, Inc. Pipeline Products by Trial Phase 14
Endologix, Inc. Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *